{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:36:23Z","timestamp":1786988183285,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejvs.2025.12.040","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T16:59:40Z","timestamp":1766422780000},"page":"964-972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Impact of Outpatient Pathways and Pre-Admission Diagnosis on Short Term Mortality and Amputation Risk after Revascularisation in Women and Men With Peripheral Arterial Disease, and Analysis of Health Insurance Claims Data"],"prefix":"10.1016","volume":"71","author":[{"given":"Jenny","family":"L\u00fcbcke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5832-8410","authenticated-orcid":false,"given":"Frederik","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1411-4303","authenticated-orcid":false,"given":"Laura","family":"Acar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2607-8996","authenticated-orcid":false,"given":"Ursula","family":"Marschall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"S\u00f8gaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0406-3319","authenticated-orcid":false,"given":"Christian-Alexander","family":"Behrendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2025.12.040_bib1","article-title":"Peripheral artery disease in Germany (2009\u20132018): prevalence, frequency of specialized ambulatory care and use of guideline-recommended therapy - a population-based study","volume":"5","author":"Rammos","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.ejvs.2025.12.040_bib2","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ejvs.2023.01.002","article-title":"Editor's Choice \u2013 prevalence of peripheral arterial disease, abdominal aortic aneurysm, and risk factors in the Hamburg City Health Study: a cross sectional analysis","volume":"65","author":"Behrendt","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2025.12.040_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejvs.2019.08.006","article-title":"Editor's Choice \u2013 comorbidity patterns among patients with peripheral arterial occlusive disease in Germany: a trend analysis of health insurance claims Data","volume":"59","author":"Kreutzburg","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2025.12.040_bib4","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ejvs.2023.08.005","article-title":"Epidemiological trends and projections of incidence, prevalence, and disease related mortality associated with peripheral arterial disease: observations using nationwide Danish data","volume":"66","author":"Sogaard","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2025.12.040_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2023.08.067","article-title":"Editor's Choice \u2013 European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral arterial disease and intermittent claudication","volume":"67","author":"Nordanstig","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2025.12.040_bib6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ejvs.2023.07.020","article-title":"Editor's Choice \u2013 the intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes mellitus and a foot ulcer","volume":"66","author":"Fitridge","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2025.12.040_bib7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/1741826710389368","article-title":"Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?","volume":"18","author":"Sigvant","year":"2011","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.ejvs.2025.12.040_bib8","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.3390\/jcm11133666","article-title":"The frequency of primary healthcare contacts preceding the diagnosis of lower-extremity arterial disease: do women consult general practice differently?","volume":"11","author":"Porras","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejvs.2025.12.040_bib9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejvs.2011.09.016","article-title":"Two-year vascular hospitalisation rates and associated costs in patients at risk of atherothrombosis in France and Germany: highest burden for peripheral arterial disease","volume":"43","author":"Smolderen","year":"2012","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2025.12.040_bib10","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s00330-021-08285-y","article-title":"In-patient care trends in peripheral artery disease in the German healthcare system over the past decade","volume":"32","author":"Decker","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejvs.2025.12.040_bib11","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.jacc.2023.09.830","article-title":"Disparities in diagnosis, treatment, and outcomes of peripheral artery disease: JACC scientific statement","volume":"82","author":"McDermott","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2025.12.040_bib12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejvs.2020.05.001","article-title":"Editor's Choice \u2013 optimal pharmacological treatment of symptomatic peripheral arterial occlusive disease and evidence of female patient disadvantage: an analysis of health insurance claims data","volume":"60","author":"Peters","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2025.12.040_bib13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1532-5415.2003.51061.x","article-title":"Sex differences in peripheral arterial disease: leg symptoms and physical functioning","volume":"51","author":"McDermott","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ejvs.2025.12.040_bib14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12874-017-0407-4","article-title":"The impact of the lookback period and definition of confirmatory events on the identification of incident cancer cases in administrative data","volume":"17","author":"Czwikla","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ejvs.2025.12.040_bib15","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s00103-008-0646-y","article-title":"[Validation of secondary data. Strengths and limitations]","volume":"51","author":"Hoffmann","year":"2008","journal-title":"Bundesgesundh Blatt"},{"key":"10.1016\/j.ejvs.2025.12.040_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028223","article-title":"Individual mortality information in the German Pharmacoepidemiological Research Database (GePaRD): a validation study using a record linkage with a large cancer registry","volume":"9","author":"Langner","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejvs.2025.12.040_bib17","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1186\/s12889-015-1943-7","article-title":"Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study","volume":"15","author":"Ohlmeier","year":"2015","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ejvs.2025.12.040_bib18","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/MLR.0b013e31819432e5","article-title":"A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data","volume":"47","author":"van Walraven","year":"2009","journal-title":"Med Care"},{"key":"10.1016\/j.ejvs.2025.12.040_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.ejvs.2025.12.040_bib20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"key":"10.1016\/j.ejvs.2025.12.040_bib21","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/1358863X11425879","article-title":"Gender differences in cholesterol-lowering medication prescribing in peripheral artery disease","volume":"16","author":"McDermott","year":"2011","journal-title":"Vasc Med"},{"key":"10.1016\/j.ejvs.2025.12.040_bib22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10557-020-07057-y","article-title":"Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD","volume":"34","author":"Mahtta","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ejvs.2025.12.040_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2261-11-39","article-title":"Differences in presentation of symptoms between women and men with intermittent claudication","volume":"11","author":"Sigvant","year":"2011","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.ejvs.2025.12.040_bib25","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1161\/CIRCULATIONAHA.107.736108","article-title":"Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication","volume":"117","author":"McDermott","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2025.12.040_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1024\/0301-1526\/a000611","article-title":"Prevalence of cardiovascular risk factors among 28,000 employees","volume":"46","author":"Scheerbaum","year":"2017","journal-title":"Vasa"},{"key":"10.1016\/j.ejvs.2025.12.040_bib27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/CIRCRESAHA.121.320702","article-title":"Sex differences in peripheral artery disease","volume":"130","author":"Pabon","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.ejvs.2025.12.040_bib28","first-page":"601","article-title":"Sex as a key determinant of peripheral artery disease: epidemiology, differential outcomes, and proposed biological mechanisms","volume":"38","author":"Morrison","year":"2022","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ejvs.2025.12.040_bib29","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ejvs.2022.02.007","article-title":"Gender differences in outpatient peripheral artery disease management in germany: a population based study 2009\u20132013","volume":"63","author":"Messiha","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2025.12.040_bib30","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC guidelines for the management of peripheral arterial and aortic diseases","volume":"45","author":"Mazzolai","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2025.12.040_bib31","first-page":"366","article-title":"Analysis of endovascular therapy for peripheral arterial disease in all German hospitals","volume":"52","author":"Betge","year":"2023","journal-title":"Vasa"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588425013097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588425013097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T20:10:50Z","timestamp":1780863050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588425013097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1078588425013097"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2025.12.040","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Outpatient Pathways and Pre-Admission Diagnosis on Short Term Mortality and Amputation Risk after Revascularisation in Women and Men With Peripheral Arterial Disease, and Analysis of Health Insurance Claims Data","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2025.12.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society for Vascular Surgery. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}